Traitements de substitution en milieu carcéral : guide des bonnes pratiques

Laurent, Michel; Maguet, Olivier

doi:10.1016/s0013-7006(05)82377-2

Cited by 15 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…7.8% of drug addicts in French prisons received OST) [23]. In most European countries that offered OST in prison, access to and varieties of available OST programmes were heterogeneous and inconsistent [5,24].…”

Section: Current State Of Drug Treatment Health Care Efforts For Inmatesmentioning

confidence: 99%

“…After 4 months in prison, the rate of illicit use of morphine was 27% for MMT-treated prisoners and 42% for controls ( P = 0.05) [39]. The use of buprenorphine maintenance therapy in prisons has been based chiefly on results obtained outside prisons [23,25]; however, there is growing experience with buprenorphine in prisons [29]. A group of prisoners receiving buprenorphine reported for their designated post-release treatment programme significantly more often than did a comparison group receiving methadone (48% vs. 14%, respectively; P < 0.001) [40].…”

Section: Rationales For Drug Dependence Treatment In Prisonsmentioning

confidence: 99%

“…This education may include evidence of beneficial results of OST, including reduced rates of drug abuse, both in prison and after release from prison [23,25,35,36,39], less risk-taking behaviour [11,38], reduced rate of infectious disease acquisition [39,42], reduced risk for death [42], decrease in serious violent drug charges [21], reduced criminal activity after release [44] and reduced re-incarceration rate [21,42,45,46]. Outcomes and health economic data demonstrating results of studies showing the cost-effectiveness of drug maintenance therapy in prisons [21,47] should be included.…”

Section: Guidance On Overcoming Barriers To the Implementation Of Submentioning

confidence: 99%

See 2 more Smart Citations

Drug use and opioid substitution treatment for prisoners

Stöver

Michels

2010

Harm Reduction Journal

View full text Add to dashboard Cite

Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.

show abstract

Section: Current State Of Drug Treatment Health Care Efforts For Inmatesmentioning

confidence: 99%

Section: Rationales For Drug Dependence Treatment In Prisonsmentioning

confidence: 99%

Section: Guidance On Overcoming Barriers To the Implementation Of Submentioning

confidence: 99%

See 1 more Smart Citation

Drug use and opioid substitution treatment for prisoners

Stöver

Michels

2010

Harm Reduction Journal

View full text Add to dashboard Cite

show abstract

“…This is a timely review, because concern about the adequacy and quality of health services for prisoners and about equivalence of care between community and prison has become more prominent over recent years [11,12]. The World Health Organization (WHO) and United Nations Office on Drugs and Crime (UNODC) have recommended OMT in prisons, and some countries have introduced changes [8,13–15]. This is encouraging, but delivering services means more than making recommendations and changing policies.…”

mentioning

confidence: 99%

Opioid maintenance in European prisons: is the treatment gap closing?

Hedrich

Farrell²

2012

Addiction

View full text Add to dashboard Cite

“…However, there have been essential improvements in the last 10 years . Several factors affect the extent to which prisons provide MAT, including the varied prison health policies of prisons and difficulties in employing adequate numbers of high-quality prison staff (Michel and Maguet, 2005). Some people living in prisons had been prevented from entering an MAT programme because of restrictive criteria.…”

mentioning

confidence: 99%

Social Work and Health in Prisons

2023

View full text Add to dashboard Cite

Creating humane prison conditions is one of today’s greatest challenges, as penitentiary systems remain closed and hidden from the public in many countries. This edited volume studies the development of social work and health services in the penitentiary systems of Central Asia and China in the context of ongoing prison reform. It examines state efforts to apply international prison standards and to create more humane prison conditions in a difficult political environment and in the context of scarce public resources. This publication is one of the first to provide a detailed account of prison health and social work in countries in Central Asia and in China. With contributions by Zhyldyz Bakirova | Tynchtyk Estebes Uulu | Simon Fleißner | Sandugash Ismagulova |Ulla-Britt Klankwarth | Anna Konvissar | Medet Kudabekov | Ingo Ilja Michels | Dalida Mukasheva | Nugul Musaeva | Cholpon Omurakunova| Eric Orosaliev | Ulla Pape | Mariya Prilutskaya | Ehab Salah | Jarkyn Shadymanova| Zhanar Shaidullina | Sergey Soshnikov | Heino Stöver | Hang Su | Nurlan Tulkinbayev | Dinara Yessimova

show abstract

Traitements de substitution en milieu carcéral : guide des bonnes pratiques

Cited by 15 publications

References 0 publications

Drug use and opioid substitution treatment for prisoners

Drug use and opioid substitution treatment for prisoners

Opioid maintenance in European prisons: is the treatment gap closing?

Social Work and Health in Prisons

Contact Info

Product

Resources

About